boxcuttersinc

Who profits from improved patient adherence?

Aside from patients who get better health outcomes because of better adherence, who profits (either from increased revenues or lower expenses) from improved patient adherence? On the revenue side are the pharmaceuticals. The simplest and most straight-forward answer is that pharmaceuticals would profit the most. After all, more adherence means more product usage, which means … Continue reading →